Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030
BACKGROUND AND AIMS In Switzerland, the prevalence of hepatitis C virus (HCV) among people who inject drugs (PWID) has been decreasing owing to active harm reduction efforts and an aging population. Recent advances in HCV therapeutics may provide an opportunity to direct treatment to hig...
Zapisane w:
| Główni autorzy: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2017-11-01
|
| Seria: | Swiss Medical Weekly |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.smw.ch/index.php/smw/article/view/2405 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|